Exposure to guideline-recommended drugs after a first acute myocardial infarction in older adults: does deprivation matter? (Record no. 30381729)

MARC details
000 -LEADER
fixed length control field 01463 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518073017.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202101s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1099-1557
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/pds.4915
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Akator, Adjo Enyonam
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20210122
245 00 - TITLE STATEMENT
Title Exposure to guideline-recommended drugs after a first acute myocardial infarction in older adults: does deprivation matter?
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Pharmacoepidemiology and drug safety
Date of publication, distribution, etc. 02 2020
300 ## - PHYSICAL DESCRIPTION
Extent 141-149 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adrenergic beta-Antagonists
General subdivision economics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Angiotensin Receptor Antagonists
General subdivision economics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Angiotensin-Converting Enzyme Inhibitors
General subdivision economics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cohort Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Myocardial Infarction
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Practice Guidelines as Topic
General subdivision standards
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quebec
General subdivision epidemiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retrospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Socioeconomic Factors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Blais, Claudia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gamache, Philippe
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lunghi, Carlotta
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Guénette, Line
773 0# - HOST ITEM ENTRY
Title Pharmacoepidemiology and drug safety
Related parts vol. 29
-- no. 2
-- p. 141-149
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/pds.4915">https://doi.org/10.1002/pds.4915</a>
Public note Available from publisher's website

No items available.